Treatment of Hyperlipidemia

Publisher Website
Google Scholar
Abstract
OVER the past decade considerable insight into the mechanisms involved in normal and abnormal lipid transport as well as the mode of action of hypolipidemic drugs has been achieved.1 This progress has made the approach to the hyperlipidemic patient increasingly more precise and effective.It is now realized that hyperlipidemia is the sign of a heterogeneous group of disorders differing in clinical features, prognosis and, most important, responsiveness to therapy. No one diet is effective in all the lipid transport disorders. Similarly, none of the currently available hypolipidemic drugs are effective in all the hyperlipidemias, some having a very limited . . .